{"id":62175,"date":"2025-11-10T10:03:26","date_gmt":"2025-11-10T09:03:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/"},"modified":"2025-11-10T10:03:26","modified_gmt":"2025-11-10T09:03:26","slug":"ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/","title":{"rendered":"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit<\/a> in London this week, AIDS Healthcare Foundation<\/a> (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences\u2019 greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable and accessible.\n<\/p>\n

\nThe roving billboard carries an urgent demand<\/a> to Gilead and its CEO Daniel O\u2019Day to \u201cMake Lenacapavir Affordable\u201d and includes bold imagery reminding the greedy pharma company and the world that \u201cBlood Is on Your Hands\u201d for its continued insistence on putting profits before human lives. The messaging is designed to capture attention, provoke debate, and put pressure on Gilead and O\u2019Day to act now to save lives.\n<\/p>\n

\n\u201cHaving a breakthrough drug means nothing if the people most at risk can\u2019t access it. Gilead\u2019s limited licensing deal and non-transparent pricing keep lenacapavir out of reach for millions\u2014especially in middle-income countries where HIV is still rising,\u201d said AHF Europe Advocacy and Policy Manager Tamara Prinsenberg. \u201cDonations and empty promises are not access. We call on CEO Daniel O\u2019Day and governments to make equitable, affordable HIV treatment and prevention non-negotiable. Expand licensing, ensure transparency, and put people before profits.\u201d\n<\/p>\n

\nAHF partner Public Citizen warns that Gilead\u2019s control of lenacapavir is \u201ca textbook case of how corporate power can derail public health,\u201d according to Peter Maybarduk, Director of the organization’s Access to Medicines program. \u201cWe have the science to prevent HIV transmission. What\u2019s missing is the courage from governments and donors to confront Gilead\u2019s power,\u201d he said.\n<\/p>\n

\nLenacapavir is a long-acting HIV prevention medication that requires only two injections per year when used for pre-exposure prophylaxis (PrEP), drastically reducing the risk of HIV infection and increasing treatment adherence. Clinical trial data showed that 99.9% of participants<\/a> who received it remained HIV negative.\n<\/p>\n

\nVisit this website<\/a> to learn more about how Gilead\u2019s greed limits access to lenacapavir in Latin America and what AHF and its partners are doing to combat it. The video message which will be displayed on the roving billboard can be viewed here<\/a>.\n<\/p>\n

\nAIDS Healthcare Foundation<\/b> (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 2.6 million people in 50 countries worldwide in the US, Africa, Latin America\/Caribbean, the Asia\/Pacific Region and Europe. We are currently the largest non-profit provider of HIV\/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org<\/a>, find us on Facebook: www.facebook.com\/aidshealth<\/a> and follow us on Twitter: @aidshealthcare<\/a> and Instagram: @aidshealthcare<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nUS MEDIA CONTACT:
\n
Ged Kenslea, <\/b>Senior Director, Communications, AHF
\n
+1 323.308.1833 work +1.323.791.5526 mobile
\n
gedk@aidshealth.org<\/a>\n<\/p>\n

\nDenys Nazarov, <\/b>Director of Global Policy and Communications, AHF
\n
+1 323.308.1829
\n
denys.nazarov@aidshealth.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit in London this week, AIDS Healthcare Foundation (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences\u2019 greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62175","6":"format-standard","7":"category-industry"},"yoast_head":"\nAHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit in London this week, AIDS Healthcare Foundation (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences\u2019 greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-10T09:03:26+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit\",\"datePublished\":\"2025-11-10T09:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/\"},\"wordCount\":478,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/\",\"name\":\"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2025-11-10T09:03:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/","og_locale":"en_US","og_type":"article","og_title":"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit in London this week, AIDS Healthcare Foundation (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences\u2019 greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-10T09:03:26+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit","datePublished":"2025-11-10T09:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/"},"wordCount":478,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/","url":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/","name":"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2025-11-10T09:03:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ahfs-mobile-billboard-calls-out-gileads-greed-at-pharma-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AHF\u2019s Mobile Billboard Calls Out Gilead\u2019s Greed at Pharma Summit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62175"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62175\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}